ClinicalTrials.gg
Sign In

Arthritis, Psoriatic clinical trials

The registry lists 600 studies for Arthritis, Psoriatic across more than 10 countries. 129 are recruiting or about to start. 386 of them are mainly about Arthritis, Psoriatic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 659 studies for Arthritis, Psoriatic. How that becomes 599 here

This page counts the studies the registry files under Arthritis, Psoriatic, and those it files under no condition that list Arthritis, Psoriaticthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 659Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −20List Arthritis, Psoriatic as a condition, but the registry did not file them under itMost often written as “Juvenile Psoriatic Arthritis” (9), “Axial Psoriatic Arthritis (axPsA)” (2), and “Arthritis, Psoriatic, Psoriasis” (1). The registry filed them under other conditions only, most often Arthritis, Juvenile (12) and Arthritis (5).
  3. −40Match it another way30 name it in the title, 4 in a keyword, and 6 by a synonym or other text the search reads.
  4. 599The count on this page5 of them list Arthritis, Psoriatic in their own words; the registry filed them under no condition.

Get an email when these change. Save the Arthritis, Psoriatic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
340
Recruiting
89
Active, not recruiting
42
Status unknown
39
Terminated
30
Not yet recruiting
29

Phase

Phase 3
107
Phase 2
67
Phase 4
48
Phase 1
31
Early Phase 1
3

Where

United States
193
Germany
109
Canada
99
Spain
96
United Kingdom
94
Poland
92

Who runs them

Novartis Pharmaceuticals (28) · AbbVie (25) · Amgen (21) · Pfizer (21) · Janssen Research & Development, LLC (19) · Bristol-Myers Squibb (12) · UCB Biopharma SRL (12) · University of Oxford (9)

What is being tested here

Drugs under test in Arthritis, Psoriatic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Guselkumab5714
Adalimumab5513
Methotrexate5410
Apremilast3817
Ixekizumab349
Risankizumab338
Zasocitinib345
Secukinumab21626
Bimekizumab2814
Etanercept2614

Drug classes tested here JAK inhibitors 8 open · Tyrosine kinase inhibitors (TKIs) 8 open · Antimetabolites 5 open · GLP-1 receptor agonists 2 open · Statins 3

Coming up

26phase 3 studies under way
53studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 89 Arthritis, Psoriatic studies recruiting now, 54 (61%) set no upper age limit and 26 (29%) stop at 75 or younger. 12 (13%) take children under 18. 4 (4%) are for women only and 1 (1%) for men only; 12 (13%) take healthy volunteers.

Recruiting studies that take each age, of 89
AgeWomenMen
1010 (11%)8 (9%)
1884 (94%)80 (90%)
3085 (96%)81 (91%)
4085 (96%)81 (91%)
5086 (97%)83 (93%)
6583 (93%)80 (90%)
7572 (81%)69 (78%)
8561 (69%)58 (65%)

Across all 600 studies, recruiting or not: 22% stop at 75 or younger and 10% at 65; 9% take children; 3% are for women only and 1% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Arthritis, Psoriatic studies take

Of 74 phase 3 interventional studies under Arthritis, Psoriatic, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 115 mo5–35 · 15 studies——
Phase 219 mo13–31 · 34 studies——
Phase 328 mo19–42 · 74 studies27 mo18–39 · 68 studies—
Phase 429 mo25–37 · 33 studies——
Interventional, no phase31 mo13–44 · 72 studies—31 mo16–43 · 67 studies
Observational47 mo28–83 · 128 studies47 mo32–63 · 52 studies53 mo20–… · 76 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 600. Browse all 600 → or search them.